Skip to main content
SpringerLink
Log in

Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal Tract

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

The sinonasal tract may give rise to a broad range of neoplasms that share a “small round blue cell” tumor (SBRCT) appearance on routine histology, but treatment strategies depend on precise tumor classification. Immunohistochemistry for p63 is often employed in the sinonasal SRBCT differential diagnosis because it is highly sensitive for squamous cell carcinoma (SCC). However, p63 staining may be observed in other tumor types, a potential diagnostic pitfall. P40 is a more squamous-specific isoform of p63, and it may be more useful in distinguishing poorly differentiated SCC from its mimickers in the sinonasal tract. Immunohistochemistry for p40 and p63 was performed on 171 sinonasal neoplasms with SRBCT morphology: 73 SCCs (67 poorly differentiated, non-keratinizing, or basaloid types and 6 nasopharyngeal carcinomas), 46 esthesioneuroblastomas, 11 sinonasal undifferentiated carcinomas (SNUCs), 11 lymphomas, 9 melanomas, 7 alveolar rhabdomyosarcomas, 4 solid adenoid cystic carcinomas, 4 NUT midline carcinomas, 4 primitive neuroectodermal tumors (PNETs), and 2 small cell carcinomas. P40 was positive in 72 of 73 SCCs, and showed a diffuse distribution in all but one positive case. P40 immunoexpression was also observed in 13 of 46 (28 %) esthesioneuroblastomas, 6 of 11 (55 %) SNUCs, 2 of 4 (50 %) adenoid cystic carcinomas, 3 of 4 (75 %) NUT midline carcinomas, 1 of 2 (50 %) small cell carcinomas, and 1 of 4 (25 %) PNETs; in the non-SCC tumors, p40 staining was focal in most cases. P63 was positive in every p40-positive tumor. In addition, a p63+/p40− phenotype was seen 5 of 11 (45 %) lymphomas, 4 of 7 (57 %) alveolar rhabdomyosarcomas, 1 of 4 (25 %) PNETs, and 3 of 46 (7 %) esthesioneuroblastomas. All sinonasal melanomas were negative for both markers. In the sinonasal SRBCT differential diagnosis, both p40 and p63 are highly sensitive for SCC, but p40 is more specific. Notably, p40 is consistently negative in lymphomas and alveolar rhabdomyosarcomas, two tumors that are frequently p63-positive. It must be remembered, however, that even diffuse p40 immunostaining is not entirely specific for the squamous phenotype, and therefore it should be utilized as part of an immunohistochemical panel.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Iezzoni JC, Mills SE. “Undifferentiated” small round cell tumors of the sinonasal tract: differential diagnosis update. Am J Clin Pathol. 2005;124(Suppl):S110–21.

    PubMed  Google Scholar 

  2. Chapman-Fredricks J, Jorda M, Gomez-Fernandez C. A limited immunohistochemical panel helps differentiate small cell epithelial malignancies of the sinonasal cavity and nasopharynx. Appl Immunohistochem Mol Morphol. 2009;17(3):207–10.

    Article  CAS  PubMed  Google Scholar 

  3. Bridge JA, Bowen JM, Smith RB. The small round blue cell tumors of the sinonasal area. Head Neck Pathol. 2010;4(1):84–93.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Mills SE, Fechner RE. “Undifferentiated” neoplasms of the sinonasal region: differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features. Semin Diagn Pathol. 1989;6(4):316–28.

    CAS  PubMed  Google Scholar 

  5. Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol. 2011;35(12):1786–93.

    Article  PubMed  Google Scholar 

  6. Bourne TD, Bellizzi AM, Stelow EB, Loy AH, Levine PA, Wick MR, et al. p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract. Am J Clin Pathol. 2008;130(2):213–8.

    Article  PubMed  Google Scholar 

  7. Stelow EB, Mills SE. Neural, neuroectodermal, and neuroendocrine neoplasms. Biopsy interpretation of the upper aerodigestive tract and ear. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 149.

  8. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol. 2012;25(3):405–15.

    Article  CAS  PubMed  Google Scholar 

  9. Fukushima N, Satoh T, Sueoka N, Sato A, Ide M, Hisatomi T, et al. Clinico-pathological characteristics of p63 expression in B-cell lymphoma. Cancer Sci. 2006;97(10):1050–5.

    Article  CAS  PubMed  Google Scholar 

  10. Emanuel P, Wang B, Wu M, Burstein DE. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol. 2005;18(5):645–50.

    Article  PubMed  Google Scholar 

  11. Park CK, Oh YH. Expression of p63 in reactive hyperplasias and malignant lymphomas. J Korean Med Sci. 2005;20(5):752–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Crum CP, McKeon FD. P63 in epithelial survival, germ cell surveillance, and neoplasia. Ann Rev Pathol. 2010;5(Journal Article):349–71.

    Google Scholar 

  13. Lin Z, Liu M, Li Z, Kim C, Lee E, Kim I. DeltaNp63 protein expression in uterine cervical and endometrial cancers. J Cancer Res Clin Oncol. 2006;132(12):811–6.

    Article  CAS  PubMed  Google Scholar 

  14. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad USA. 2000;97(10):5462–7.

    Article  CAS  Google Scholar 

  15. Pelosi G, Sonzogni A, Papotti M, Righi L, Rossi G, Viale G. Different prevalence of transactivating (TA) p63 and non-TAp63 isoforms in pulmonary adenocarcinomas: a useful diagnostic tool. Mod Pathol. 2010;23(1s):411A–2A.

    Google Scholar 

  16. Righi L, Graziano P, Fornari A, Rossi G, Barbareschi M, Cavazza A, et al. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Cancer. 2011;117(15):3416–23.

    Article  CAS  PubMed  Google Scholar 

  17. Del Vescovo V, Cantaloni C, Cucino A, Girlando S, Silvestri M, Bragantini E, et al. miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am J Surg Pathol. 2011;35(2):268–75.

    Article  PubMed  Google Scholar 

  18. Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2):185–92.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Tilson MP, Gallia GL, Bishop JA. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas. Head Neck Pathol. 2013. In Press. doi:10.1007/s12105-013-0475-7.

  20. Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol. 2012;36(8):1216–21.

    Article  PubMed  Google Scholar 

  21. French CA. NUT midline carcinoma. Cancer Genet Cytogenet. 2010;203(1):16–20.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol. 2011;5(1):31–5.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Pelosi G, Fabbri A, Rossi G, Maisonneuve P, Sonzogni A, Bresaola E, et al. A two-hit minimalist diagnostic algorithm based on p40 (deltaNp63) and TTF-1 immunostaining upon small biopsy/cellblock samples for differentiating main subtypes of non-small cell lung cancer and sparing material. J Thorac Oncol. 2011;6(6):S335–6.

    Google Scholar 

  24. Uramoto H, Yamada S, Hanagiri T. Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung. Anticancer Res. 2010;30(11):4717–20.

    PubMed  Google Scholar 

  25. Iacono ML, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M, et al. p63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue. J Thorac Oncol. 2011;6(3):473–81.

    Article  PubMed  Google Scholar 

  26. Serrano MF, El-Mofty SK, Gnepp DR, Lewis JS Jr. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol. 2008;39(4):591–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Matthew P. Tilson & Justin A. Bishop

  2. The Johns Hopkins University School of Medicine, 401 N. Broadway, Weinberg 2249, Baltimore, MD, 21231, USA

    Matthew P. Tilson & Justin A. Bishop

Authors
  1. Matthew P. Tilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Justin A. Bishop
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Justin A. Bishop.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tilson, M.P., Bishop, J.A. Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal Tract. Head and Neck Pathol 8, 141–145 (2014). https://doi.org/10.1007/s12105-013-0496-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-013-0496-2

Keywords

Search

Navigation